Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis.

Saved in:

Bibliographic Details
Title:	Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis.
Authors:	Blauvelt, Andrew¹ (AUTHOR), Gordon, Kenneth B.² (AUTHOR), Lee, Patricia³ (AUTHOR), Bagel, Jerry⁴ (AUTHOR), Sofen, Howard⁵ (AUTHOR), Lockshin, Benjamin^6,7,8 (AUTHOR), Soliman, Ahmed M.⁹ (AUTHOR), Geng, Ziqian⁹ (AUTHOR), Zhan, Tianyu⁹ (AUTHOR), Alperovich, Gabriela¹⁰ (AUTHOR), Stein Gold, Linda¹¹ (AUTHOR)
Source:	Journal of Dermatological Treatment. Jun2022, Vol. 33 Issue 4, p2085-2093. 9p.
Database:	Academic Search Ultimate

Description
ISSN:	09546634
DOI:	10.1080/09546634.2021.1914812